These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19479389)

  • 1. [Immunosuppression after heart and lung transplantation].
    Wendler O; Schäfers HJ
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():3-7. PubMed ID: 19479389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New immunosuppressive regimens in lung transplantation.
    Briffa N; Morris RE
    Eur Respir J; 1997 Nov; 10(11):2630-7. PubMed ID: 9426106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in immunosuppression for lung transplantation.
    Floreth T; Bhorade SM
    Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of acute rejection prevents chronic rejection in a rat model of allogenic left lung transplantation.
    Hirt SW; You XM; Möller F; Boeke K; Ernst M; Starke M; Spranger U; Wottge HU
    Transplant Proc; 1998 Jun; 30(4):1005-6. PubMed ID: 9636406
    [No Abstract]   [Full Text] [Related]  

  • 5. Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.
    Hoffmeyer F; Hoeper MM; Spiekerkötter E; Harringer W; Haverich A; Fabel H; Niedermeyer J
    Transplantation; 2000 Aug; 70(3):522-5. PubMed ID: 10949197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional and novel approaches to immunosuppression.
    Floreth T; Bhorade SM; Ahya VN
    Clin Chest Med; 2011 Jun; 32(2):265-77. PubMed ID: 21511089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after bronchiolitis obliterans syndrome.
    Yerkovich ST; Hopkins PM; Chambers DC
    Am J Respir Crit Care Med; 2011 Feb; 183(4):554; author reply 554-5. PubMed ID: 21325085
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with cyclosporine: from revolution to evolution of immunosuppressive protocols in thoracic organ transplantation.
    Haverich A; Gorler H
    Transplant Proc; 2004 Mar; 36(2 Suppl):314S-317S. PubMed ID: 15041360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression for lung transplantation.
    Bhorade SM; Stern E
    Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graft immunity in lung transplantation].
    Mornex JF
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):257-66. PubMed ID: 12844023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction immunosuppression for lung transplantation with OKT3.
    Wain JC; Wright CD; Ryan DP; Zorb SL; Mathisen DJ; Ginns LC
    Ann Thorac Surg; 1999 Jan; 67(1):187-93. PubMed ID: 10086547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.
    Singh TP; Faber C; Blume ED; Worley S; Almond CS; Smoot LB; Dillis S; Nasman C; Boyle GJ
    J Heart Lung Transplant; 2010 May; 29(5):517-22. PubMed ID: 20061164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.
    Gauthier JM; Ruiz-Pérez D; Li W; Hachem RR; Puri V; Gelman AE; Kreisel D
    Transplantation; 2018 Sep; 102(9):1459-1466. PubMed ID: 29683998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation.
    Ross DJ; Lewis MI; Kramer M; Vo A; Kass RM
    Chest; 1997 Nov; 112(5):1175-9. PubMed ID: 9367453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression: what's standard and what's new?
    Witt CA; Hachem RR
    Semin Respir Crit Care Med; 2013 Jun; 34(3):405-13. PubMed ID: 23821513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic induction therapy in heart and lung transplantation: the protagonist opinion.
    Wahlers T
    Transplant Proc; 1998 Jun; 30(4):1100-3. PubMed ID: 9636447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.